NCT00449592View on ClinicalTrials.gov

Oral Zinc Therapy for the Prevention of Mucositis

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Mucositis
Interventions
DRUG

Zinc

Oral Zincol 1 Tab TID from day -6/-7 until discharge

DRUG

Placebo

Oral placebo 1 Tab TID from day -6/-7 until discharge

Trial Locations (1)

Unknown

Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Ramat Gan

All Listed Sponsors
lead

Sheba Medical Center

OTHER_GOV

NCT00449592 - Oral Zinc Therapy for the Prevention of Mucositis | Biotech Hunter | Biotech Hunter